Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Volume 22, Number 6—June 2016

Dispatch

MERS-CoV Antibodies in Humans, Africa, 2013–2014

Anne M. Liljander1, Benjamin Meyer1, Joerg Jores, Marcel A. Müller, Erik Lattwein, Ian Njeru, Bernard Bett, Christian DrostenComments to Author , and Victor Max Corman
Author affiliations: International Livestock Research Institute, Nairobi, Kenya (A. Liljander, J. Jores, B. Bett); University of Bonn Medical Centre, Bonn, Germany (B. Meyer, M.A. Müller, C. Drosten, V.M. Corman); University of Bern, Vetsuisse Faculty, Bern, Switzerland (J. Jores); EUROIMMUN AG, Lübeck, Germany (E. Lattwein); Ministry of Health, Nairobi, Kenya (I. Njeru); German Centre for Infection Research, Bonn (C. Drosten, V.M. Corman)

Main Article

Table

Seropositivity for Middle East respiratory syndrome coronavirus in samples from humans in Kenya, 2013–2014*

County No. samples tested No. (%) positive by rELISA No. (%) positive by rELISA and with >50% plaque reduction at 1:20 dilution
Garissa 559 4 (0.72) 0
Tana River 563 12 (2.13) 2 (0.36)
Total 1,122 16 (1.43) 2 (0.18)

*rELISA, recombinant ELISA.

Main Article

1These authors contributed equally to this article.

TOP